CHM chimeric therapeutics limited

I think you are underestimating the valuation of CHM if any of...

  1. 294 Posts.
    lightbulb Created with Sketch. 92
    I think you are underestimating the valuation of CHM if any of its therapies prove effective....

    If CDH17 CART proves effective in the Phase 1 dose escalation and we move to Phase 2 later this year, our market cap should be $200m+.....

    Reality is we are the only CART targeting CDH17 in an FDA IND globally. GI cancer market is USD25bn per annum....huge!

    I would also expect FDA designations, strategic partnerships with big pharma along the way.......


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.